FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:1624-1625 November 14, 2002 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Hata, A. PubMed Citation

To the Editor: Hata et al. (July 4 issue)¹ report that inactivated varicella vaccine given before and after hematopoietic-cell transplantation reduces the risk of zoster. The primary end point of their study was the development of zoster within 12 months after transplantation. We believe, however, that the follow-up is too short to support a definite conclusion concerning the effect of vaccination. Offidani et al.² reported that the actuarial probability of varicella–zoster virus infection in 164 recipients of autologous hematopoietic-cell transplants was 10 percent at one year, 17 percent at two years, and 24 percent at three years. In the study . . . [Full Text of this Article]

This article has been cited by other articles:

• Vassalli, G., Winkelmann, B. R (2004). Molecular genetics of myocardial infarction: many genes, more questions than answers. Eur Heart J 25: 451-453 [Full Text]